PATENT CLAIM ANALYSIS

Application Number: 16080617
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "174100"]

Abstract:
This invention provides a method that combines a checkpoint inhibitor and a glucocorticoid receptor modulator to treat cancer, e.g., a checkpoint inhibitor sensitive cancer.

Claim (Index 1):
A method for treating a patient hosting a tumor load, the method comprising administering to the patient a therapeutic amount of a checkpoint inhibitor and a selective glucocorticoid receptor modulator (SGRM) where the SGRM is administered in an amount effective to potentiate the activity of the checkpoint inhibitor and reduce the tumor load of the patient.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.35
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15942312', '15697878', '15915477', '15500618', '15809759']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7087948136345644
- 35 USC 102 Novelty (BERT): 0.522273330444523
- Combined Prediction Score: 0.6901426653155602
- Mean Citation Score: 297.060654
- Max Citation Score: 317.0144
- Similarity Product: 245.4972160303116

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test